ROCCO, WILLIAM L.,罗可 威廉 L,羅可 威廉 L,MULLER, FRANCIS X.,穆勒 法兰西斯 X,穆勒 法蘭西斯 X
申请号:
TW108122789
公开号:
TW202010501A
申请日:
2019.06.28
申请国别(地区):
TW
年份:
2020
代理人:
摘要:
The present application relates to pharmaceutical formulations and dosage forms of an AXL/MER inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of AXL/MER mediated diseases such as cancer.本申請案係關於AXL/MER抑制劑、或其醫藥學上可接受之鹽、溶劑合物、或水合物之醫藥調配物及劑型,包括其製備方法,該等調配物適用於治療經AXL/MER介導之疾病,諸如癌症。